For US residents only

How KYMRIAH May Help

< Back To Site

Prescribing Info including Med Guide

Patient Support Line
1-844-459-6742
8 am-8 pm ET

Important Safety Information, including Boxed WARNING:

What is the most important information I should know about KYMRIAH? KYMRIAH may cause side effects that are severe or life-threatening, such as cytokine release syndrome (CRS) and neurological ...

Approved Use:

What is KYMRIAH? KYMRIAH is made from your own white blood cells and is a prescription cancer treatment used in patients up to 25 years of age who have acute lymphoblastic leukemia (ALL) that has relapsed (went into remission, then came back) or is refractory (did not go into remissi...

Relapsed/refractory (r/r) B-cell acute lymphoblastic leukemia (ALL) treatment, individualized just for you

KYMRIAH^® (tisagenlecleucel) was originally studied in a global clinical trial of children and young adults with relapsed or refractory B-cell ALL, with many achieving an early and lasting remission. While many patients have been successfully treated with KYMRIAH, not all patients will respond the same way.

What are the long-term results?

Since KYMRIAH was approved, patients from the clinical trial have been followed to see how well they do over the course of years. A long-term follow-up of patients in the clinical trial was done at 24 months from the date of infusion of KYMRIAH.

Downloadable Resources

Download helpful materials to support you throughout KYMRIAH therapy.

KYMRIAH CARES

Learn about KYMRIAH CARES^™, a program that has resources to help you throughout your treatment journey.

Speak With A Real Patient

The Leukemia & Lymphoma Society (LLS) provides The Patti Robinson Kaufmann First Connection Program, which offers peer-to-peer support from patients, family members, caregivers, or peer volunteers who have gone through a similar experience

Next: What to Expect With KYMRIAH >